Merck & Co., Inc., 10% Owner at Harpoon Therapeutics, Inc. (HARP), bought 21,397,205 shares at $23.00 ($492.1M) on 2024-03-11, disclosed to the SEC on 2024-03-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |